Free Trial

Sustainable Insight Capital Management LLC Lowers Stock Holdings in The Allstate Co. (NYSE:ALL)

Allstate logo with Finance background

Sustainable Insight Capital Management LLC cut its holdings in The Allstate Co. (NYSE:ALL - Free Report) by 22.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 17,000 shares of the insurance provider's stock after selling 4,900 shares during the period. Allstate accounts for 1.5% of Sustainable Insight Capital Management LLC's investment portfolio, making the stock its 28th biggest position. Sustainable Insight Capital Management LLC's holdings in Allstate were worth $3,224,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of ALL. Allspring Global Investments Holdings LLC boosted its holdings in shares of Allstate by 18.7% in the third quarter. Allspring Global Investments Holdings LLC now owns 3,000,866 shares of the insurance provider's stock worth $569,114,000 after acquiring an additional 472,040 shares during the period. Raymond James & Associates lifted its holdings in Allstate by 10.6% during the 3rd quarter. Raymond James & Associates now owns 1,517,800 shares of the insurance provider's stock worth $287,851,000 after purchasing an additional 145,986 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in Allstate by 3.4% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,437,688 shares of the insurance provider's stock worth $229,545,000 after purchasing an additional 47,038 shares during the period. Pathway Financial Advisers LLC grew its holdings in Allstate by 18,472.5% during the 3rd quarter. Pathway Financial Advisers LLC now owns 1,052,687 shares of the insurance provider's stock valued at $199,642,000 after buying an additional 1,047,019 shares in the last quarter. Finally, Hsbc Holdings PLC increased its position in shares of Allstate by 3.3% during the second quarter. Hsbc Holdings PLC now owns 1,007,953 shares of the insurance provider's stock valued at $160,948,000 after buying an additional 31,789 shares during the period. 76.47% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Allstate

In other Allstate news, insider John E. Dugenske sold 36,367 shares of the company's stock in a transaction that occurred on Friday, September 20th. The stock was sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the sale, the insider now directly owns 27,364 shares in the company, valued at $5,236,922.32. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link. In other Allstate news, EVP Elizabeth Brady sold 49,481 shares of the firm's stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $179.09, for a total value of $8,861,552.29. Following the completion of the sale, the executive vice president now owns 19,163 shares of the company's stock, valued at $3,431,901.67. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider John E. Dugenske sold 36,367 shares of the company's stock in a transaction that occurred on Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the transaction, the insider now directly owns 27,364 shares in the company, valued at approximately $5,236,922.32. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 192,530 shares of company stock worth $34,967,665 over the last 90 days. 1.80% of the stock is owned by insiders.

Allstate Stock Performance

Allstate stock traded up $6.35 during midday trading on Friday, reaching $196.90. 2,018,725 shares of the company traded hands, compared to its average volume of 1,555,754. The firm has a market capitalization of $52.14 billion, a price-to-earnings ratio of 12.75, a price-to-earnings-growth ratio of 1.76 and a beta of 0.48. The Allstate Co. has a 12 month low of $128.33 and a 12 month high of $198.79. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.40 and a quick ratio of 0.40. The business has a 50 day moving average of $189.09 and a two-hundred day moving average of $175.85.

Allstate (NYSE:ALL - Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, beating analysts' consensus estimates of $2.20 by $1.71. The company had revenue of $16.63 billion during the quarter, compared to analyst estimates of $14.57 billion. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The firm's revenue was up 14.7% on a year-over-year basis. During the same period in the prior year, the company earned $0.81 earnings per share. As a group, research analysts predict that The Allstate Co. will post 15.34 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on ALL. JPMorgan Chase & Co. boosted their price objective on shares of Allstate from $205.00 to $207.00 and gave the company an "overweight" rating in a research note on Thursday, October 10th. Keefe, Bruyette & Woods boosted their price target on shares of Allstate from $222.00 to $225.00 and gave the company an "outperform" rating in a research report on Wednesday. TD Cowen upped their price target on shares of Allstate from $193.00 to $224.00 and gave the stock a "buy" rating in a report on Tuesday, September 3rd. Morgan Stanley lifted their price objective on Allstate from $220.00 to $228.00 and gave the company an "overweight" rating in a research note on Thursday. Finally, Wells Fargo & Company upped their target price on Allstate from $175.00 to $186.00 and gave the stock an "equal weight" rating in a research note on Tuesday, November 5th. One research analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, Allstate has an average rating of "Moderate Buy" and an average price target of $212.56.

Get Our Latest Research Report on Allstate

Allstate Company Profile

(Free Report)

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

Featured Stories

Institutional Ownership by Quarter for Allstate (NYSE:ALL)

Should you invest $1,000 in Allstate right now?

Before you consider Allstate, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.

While Allstate currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines